For help on how to get the results you want, see our search tips.
1743 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Withdrawn applications Remove Withdrawn applications filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Dafiro HCT (updated)
Amlodipine besylate, valsartan, hydrochlorothiazide, Hypertension
Date of authorisation: 03/11/2009, Revision: 19, Authorised, Last updated: 07/07/2020 -
List item
Human medicine European public assessment report (EPAR): Cotellic (updated)
cobimetinib hemifumarate, Melanoma
Date of authorisation: 20/11/2015,
, Revision: 8, Authorised, Last updated: 07/07/2020
-
List item
Human medicine European public assessment report (EPAR): Zerbaxa (updated)
ceftolozane sulfate, tazobactam sodium, Bacterial Infections
Date of authorisation: 18/09/2015, Revision: 12, Authorised, Last updated: 07/07/2020 -
List item
Human medicine European public assessment report (EPAR): Exforge HCT (updated)
Amlodipine besylate, valsartan, hydrochlorothiazide, Hypertension
Date of authorisation: 15/10/2009, Revision: 17, Authorised, Last updated: 07/07/2020 -
List item
Human medicine European public assessment report (EPAR): Buvidal (updated)
buprenorphine, Opioid-Related Disorders
Date of authorisation: 20/11/2018, Revision: 3, Authorised, Last updated: 07/07/2020 -
List item
Human medicine European public assessment report (EPAR): Ondexxya (updated)
andexanet alfa, Drug-Related Side Effects and Adverse Reactions
Date of authorisation: 26/04/2019,, 
, Revision: 4, Authorised, Last updated: 07/07/2020
-
List item
Human medicine European public assessment report (EPAR): Taltz (updated)
ixekizumab, Psoriasis
Date of authorisation: 25/04/2016,, Revision: 10, Authorised, Last updated: 07/07/2020
-
List item
Human medicine European public assessment report (EPAR): PritorPlus (updated)
telmisartan, hydrochlorothiazide, Hypertension
Date of authorisation: 22/04/2002, Revision: 35, Authorised, Last updated: 07/07/2020 -
List item
Human medicine European public assessment report (EPAR): Nevanac (updated)
nepafenac, Pain, Postoperative, Ophthalmologic Surgical Procedures
Date of authorisation: 11/12/2007, Revision: 16, Authorised, Last updated: 06/07/2020 -
List item
Human medicine European public assessment report (EPAR): Tavlesse (updated)
Fostamatinib disodium, Thrombocytopenia
Date of authorisation: 09/01/2020,, Revision: 2, Authorised, Last updated: 06/07/2020
-
List item
Human medicine European public assessment report (EPAR): Cayston (updated)
aztreonam lysine, Cystic Fibrosis, Respiratory Tract Infections
Date of authorisation: 21/09/2009, Revision: 18, Authorised, Last updated: 06/07/2020 -
List item
Human medicine European public assessment report (EPAR): Trizivir (updated)
abacavir (as sulfate), lamivudine, zidovudine, HIV Infections
Date of authorisation: 27/12/2000, Revision: 34, Authorised, Last updated: 06/07/2020 -
List item
Human medicine European public assessment report (EPAR): Stribild (updated)
elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 24/05/2013, Revision: 22, Authorised, Last updated: 06/07/2020 -
List item
Human medicine European public assessment report (EPAR): Intuniv (updated)
guanfacine hydrochloride, Attention Deficit Disorder with Hyperactivity
Date of authorisation: 17/09/2015,, Revision: 7, Authorised, Last updated: 06/07/2020
-
List item
Human medicine European public assessment report (EPAR): Afinitor (updated)
everolimus, Carcinoma, Renal Cell, Breast Neoplasms, Pancreatic Neoplasms
Date of authorisation: 02/08/2009, Revision: 25, Authorised, Last updated: 06/07/2020 -
List item
Human medicine European public assessment report (EPAR): Biktarvy (updated)
bictegravir, emtricitabine, tenofovir alafenamide, fumarate, HIV Infections
Date of authorisation: 21/06/2018,, Revision: 6, Authorised, Last updated: 03/07/2020
-
List item
Human medicine European public assessment report (EPAR): Synjardy (updated)
empagliflozin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 27/05/2015,, Revision: 16, Authorised, Last updated: 03/07/2020
-
List item
Human medicine European public assessment report (EPAR): Thymanax (updated)
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009,
Date of refusal: 18/11/2006, Revision: 21, Authorised, Last updated: 03/07/2020 -
List item
Human medicine European public assessment report (EPAR): Valdoxan (updated)
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009, Revision: 21, Authorised, Last updated: 03/07/2020 -
List item
Human medicine European public assessment report (EPAR): Zoely (updated)
Nomegestrol acetate, estradiol, Contraception
Date of authorisation: 26/07/2011,, Revision: 19, Authorised, Last updated: 03/07/2020
-
List item
Human medicine European public assessment report (EPAR): Combivir (updated)
lamivudine, zidovudine, HIV Infections
Date of authorisation: 18/03/1998, Revision: 30, Authorised, Last updated: 03/07/2020 -
List item
Human medicine European public assessment report (EPAR): Flixabi (updated)
infliximab, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 26/05/2016,, 
, Revision: 14, Authorised, Last updated: 03/07/2020
-
List item
Human medicine European public assessment report (EPAR): Evra (updated)
norelgestromin, ethinyl estradiol, Contraception
Date of authorisation: 21/08/2002, Revision: 21, Authorised, Last updated: 02/07/2020 -
List item
Human medicine European public assessment report (EPAR): Dupixent (updated)
dupilumab, Dermatitis, Atopic
Date of authorisation: 27/09/2017,, Revision: 8, Authorised, Last updated: 02/07/2020
-
List item
Human medicine European public assessment report (EPAR): Vemlidy (updated)
tenofovir alafenamide fumarate, Hepatitis B
Date of authorisation: 09/01/2017,, Revision: 7, Authorised, Last updated: 02/07/2020